ArticleCancer management and research2019

Glycodelin As A Biomarker Of Advanced Lung Adenocarcinoma Brain Metastases In Patients Treated With EGFR Tyrosine Kinase Inhibitors.

Zexu Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.